Navigation Links
Starpharma and Elanco Sign Agreement
Date:5/11/2009

MELBOURNE, Australia, May 11 /PRNewswire/ -- Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the signing of a collaborative research, license and commercialisation agreement with Elanco, the animal health division of US pharmaceutical company Eli Lilly and Company.

The parties will collaborate to develop new animal health products with enhanced properties using Starpharma's dendrimer technology. Under the agreement, Starpharma will receive revenue from research fees, and is eligible for milestone payments and royalties on sale of any product developed. Elanco will receive exclusivity within the animal health field. Terms were not disclosed.

"We are very pleased to have secured such a strong animal health partner as Elanco for our delivery technology," said Dr Jackie Fairley, CEO, Starpharma.

"Their expertise, resources and market presence will be enormously valuable assets as we work to bring these innovative products to market," Fairley said. "An exciting aspect of this application for our business is that product development in the animal health sector can be faster than is usually associated with the development of human drugs."

The collaboration with Elanco is further demonstration of Starpharma's strong and successful partnership model and the multiple potential applications of its dendrimer technology. Starpharma also has partnerships with SSL International (Durex(R)), Siemens (Dade Behring), EMD Merck, Stiefel, Unilever, Qiagen and Sigma Aldrich.

Starpharma retains all rights to exploit the technology outside of Elanco's specific field of interest, including for all uses in humans, and continues to work to add to its portfolio of partners for drug delivery and dendrimer technology more widely.

In 2008, the global animal health market was reported to be about US$19 billion. Global sales are expected to reach US$21.7B by 2010, at
'/>"/>

SOURCE Starpharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms
2. Heifer and Elanco Announce Charitable Partnership
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact
9. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
10. Biomoda, Inc. and Quintiles Announce Agreement for Regulatory Consulting
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 2015 , ... Dental clinicians from Newcastle University, United Kingdom, ... learn more about its integrated approach to diabetes care. , Philip Preshaw, BDS, ... Medicine at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a non-profit ... tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits and ... help India Network members make an informed decision regarding the care they want ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:8/31/2015)... ... ... Coast Dental Vista is celebrating its recent grand opening with an ... Albertsons in the Foothill Center, located at 1279 E. Vista Way. There will be ... Call (760) 208-2518 for more details or stop by on September 5. , Coast ...
(Date:8/31/2015)... ... September 01, 2015 , ... Neuropsychiatric Disease and ... emphasis on transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore ... largely untreatable - with mostly palliative treatments only - and now we have ...
Breaking Medicine News(10 mins):Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3
... (and this naturally includes humans) is an extraordinarily complex process ... to the formation in healthy eyes of elastic and transparent ... ciliary muscles, the lens can change its degree of curvature ... a result, a pin sharp image is created on the ...
... April 7, 2008 Twin Hens(TM) has,focused its ... Beef Pot Pie,that will have you salivating for ... polenta create a flavor marriage as natural as ... winning combination into a,single serving beef pot pie ...
... Minority Populations at Greatest Risk for Developing End ... currently suffer from Kidney Disease, WASHINGTON, April ... of patient advocates, dialysis,professionals, caregivers, providers and manufacturers ... for individuals with chronic kidney,disease (CKD), today at ...
... to protect the spinal cord from toxins may play a ... as ALS or Lou Gehrigs disease, according to research published ... mark the first time that scientists have witnessed molecular changes ... finding opens up a new front in studies of ALS, ...
... Exponent,Inc. (Nasdaq: EXPO ), today announced that it ... 28, 2008, immediately following,the close of the market on ... conference call and live webcast at 4:30 p.m. Eastern ... Executive,Officer, and Richard Schlenker, Chief Financial Officer, will discuss ...
... MIDDLETON, Wis., April 7, 2008 Each year cancer ... children in the United States than,any other disease. At ... in Middleton, Wisconsin will see over 38 people from ... brave,participants will be led to a stage at Cheeseburger ...
Cached Medicine News:Health News:When poor communication pokes you in the eye 2Health News:New Twin Hens Beef Pot Pies with Organic Cornmeal Now Provide The Brand's Famous Artisan Comfort Food for Gluten-free Connoisseurs 2Health News:Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit 2Health News:Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit 3Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 2Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 3Health News:Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease 4Health News:What Would You Look Like Bald? Like a Hero to Kids With Cancer, Says the St. Baldrick's Foundation 2
(Date:8/31/2015)...  Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a ... of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, ... four investor conferences in September. , ... Company, LLC Emerging Growth Conference in ... , President & Chief Executive Officer, will present a ...
(Date:8/31/2015)... Israel , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the ... commercializes biomedical innovations in ophthalmology and cancer diagnostics, ... Technologies (TASE: MCTC), has identified several new genetic ... the jawbone in patients treated with bisphosphonate drugs ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... , NEW YORK ... (Sony) announced today that it has acquired iCyt Mission Technology, Inc. ... cell and disease research, through its U.S. subsidiary, Sony Corporation of ... technologies to enter the flow cytometry business in the life science ...
... , Feb. 9 STD Med, Inc., a manufacturer ... is pleased to announce the acquisition of a new 32,000 sq. ... addition to the current footprint of 120,000 sq. ft. "We are ... financial times," said Steven Tallarida , President STD Med, "we ...
Cached Medicine Technology:Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 2Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 3STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
Medicine Products: